Content related to Landmark International Study: CAR T-Cell Therapy Safe and Effective in Children and Young Adults with Leukemia

In 2018, Children’s Hospital Los Angeles was the first hospital in Southern California approved to deliver a new therapy to pediatric patients with acute lymphoblastic leukemia that did not respond to

The Children’s Center for Cancer and Blood Diseases (CCCBD) at Children’s Hospital Los Angeles is one of the first sites in the world to offer a promising new investigational therapy to treat

With the addition of four scientists, the team is developing new and innovative approaches to CAR-T therapy in children.

Risk of detecting cancer cells decreased by 70% after one month of treatment

Investigators at The Saban Research Institute of Children’s Hospital Los Angeles have developed and tested a new biomarker assay for quantifying disease and detecting the presence of neuroblastoma